LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
GlobeNewswire Inc.
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026LeMaitre Vascular, Inc. announced it will release its third quarter 2026 financial results on November 4, 2026, after market close, followed by a conference call at 5:00 PM EST to discuss results, business highlights, and company outlook.
Headlines open the publisher's site.
